Authors' objectives:

This study aims to assess the current evidence on interstitial laser therapy for fibroadenomas of the breast.

Authors' recommendations: 1.1 Current evidence on the safety and efficacy of interstitial laser therapy for fibroadenomas of the breast does not appear adequate for this procedure to be used without special arrangements for consent and for audit or research. 1.2 Clinicians wishing to undertake interstitial laser therapy for fibroadenomas of the breast should take the following actions. - Inform the clinical governance leads in their Trusts. - Audit and review all patients having interstitial laser therapy for fibroadenomas of the breast. - Ensure that patients understand the benign nature of fibroadenomas, and that watchful waiting is an option. Patients should be provided with clear written information and use of the Institute's Information for the public is recommended. 1.3 This procedure should be carried out only within specialist breast services. 1.4 Publication of safety and efficacy outcomes will be useful. The Institute may review the procedure upon publication of further evidence.

Authors' methods: Overview

Project Status: Completed

URL for project: http://www.nice.org.uk/ipcat.aspx?c=222012

Year Published: 2005

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: National Institute for Clinical Excellence

Contact Address: MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801

Contact Name: nice@nice.nhs.uk

Contact Email: nice@nice.nhs.uk

Copyright: National Institute for Clinical Excellence (NICE)